Diabetic macular oedema: a clinical overview
- 8 January 2007
- journal article
- review article
- Published by Hindawi Limited in International Journal of Clinical Practice
- Vol. 61 (1), 88-97
- https://doi.org/10.1111/j.1742-1241.2006.01211.x
Abstract
Diabetic retinopathy is the leading cause of blindness in working aged-adults in westernised countries. Diabetic macular oedema (DMO) is a manifestation of diabetic retinopathy and is the leading cause of the visual impairment that occurs with diabetic retinopathy. There are multiple ways of classifying DMO; however, none appear to be wholly satisfactory. DMO occurs more frequently in type 2 diabetes mellitus, and appears to be more prevalent as the duration of diabetes increases, and as the severity of diabetic retinopathy worsens. There are multiple risk factors in common with diabetic retinopathy, such as hyperglycaemia, hypertension and dyslipidaemia; however, specific factors such as the presence of renal disease appear to be more significantly associated with DMO. Whereas the gold standard for diagnosis of DMO is via clinical examination, there is considerable variability involved, and hence, this has led to the advent of more objective methods of quantifying the degree of retinal thickness, such as optical coherence tomography. Laser photocoagulation appears to be the only universally acceptable treatment of choice to date; however, this is a destructive therapy, and its side effects coupled with the suboptimal efficacy has led to the advent of potential new therapies which will undoubtedly compliment the existing approaches, in the future management of a patient with DMO.Keywords
This publication has 81 references indexed in Scilit:
- Diabetic Retinopathy and Diabetic Macular EdemaDiabetes Care, 2003
- The Potential Role of PKC β in Diabetic Retinopathy and Macular EdemaSurvey of Ophthalmology, 2002
- Diabetic retinopathyDiabetologia, 2002
- Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic ComplicationsJama-Journal Of The American Medical Association, 2002
- Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGFJCI Insight, 2002
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Vitrectomy for diabetic macular edema associated with a taut premacular posterior hyaloidCurrent Opinion in Opthalmology, 1998
- Volumetric analysis of early macular edema with the heidelberg retina tomograph in diabetic retinopathyHistorical imageOphthalmology, 1998
- The Effect of Glycaemic Control and the Introduction of Insulin Therapy on Retinopathy in Non-insulin-dependent Diabetes MellitusDiabetic Medicine, 1997
- Adverse Events and Their Association With Treatment Regimens in the Diabetes Control and Complications TrialDiabetes Care, 1995